A QUICK scan of the article by Kahn et al1 might lead the casual reader to conclude that antidepressant treatment does not reduce the risk of suicide. However, a careful analysis of the data shows that any such conclusion would be unfortunate and unsubstantiated, and that several important questions remain unanswered.
The article examines data from clinical trials that were submitted to the Food and Drug Administration as parts of 5 successful applications for indications in the treatment of depression. Among the 19 639 patients who participated in the trials, 34 committed suicide during the 4- to 8-week periods in which the trials were conducted. The authors, assuming a completely linear event-time relationship, converted this into an estimated annual rate of 757 suicides per 100 000 depressed patients treated with 1 of the 5 antidepressants. This suicide rate is nearly 70 times higher than the rate in the general population. The article indicates that this falls within the range of the estimated depressed patient suicide rates (between 275 per 100 000 and 1352 per 100 000) that the authors have found in the literature. Also, a community study in Sweden (the "Lundby" study) followed people for 25 years and found the annual suicide rate for men with a history of depression to be 650 per 100 000.2 In men whose depression caused severe impairment, the annual rate soared to 3900 per 100 000.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Psychiatry editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 17
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.